Accelerated Biosciences
1 known investors
Accelerated Biosciences develops a patented human trophoblast stem cell (hTSC) platform, licensing starting materials, protocols, and genetically engineered cell technologies to biopharma companies and research institutions. It aims to support the development of regenerative medicine therapeutics while addressing GMP and CMC challenges for its partners.
Investors Β· 1
Frequently asked questions
- What does Accelerated Biosciences do?
- Accelerated Biosciences develops a patented human trophoblast stem cell (hTSC) platform, licensing starting materials, protocols, and genetically engineered cell technologies to biopharma companies and research institutions. It aims to support the development of regenerative medicine therapeutics while addressing GMP and CMC challenges for its partners.
- Who are Accelerated Biosciences's investors?
- Accelerated Biosciences's investors include BioAdvance.